The short version
- Implant-based breast reconstruction is staged: CPT 19357 places the tissue expander (and includes subsequent expansions), then 11970 replaces the expander with the permanent implant.
- The Women’s Health and Cancer Rights Act (WHCRA) mandates coverage of all stages of reconstruction after a mastectomy — so the question is coding accuracy across stages, not whether each stage is covered.
- Most reconstructions add acellular dermal matrix: placement is the add-on +15777, the matrix product bills separately by the unit, and total anterior coverage uses far more of it than an inframammary-fold sling.
- WHCRA also covers surgery on the other breast to produce a symmetrical appearance, prostheses, and treatment of complications, including lymphedema.
- There’s no time limit: coverage can’t be denied because of how long it’s been between the mastectomy and the reconstruction request.
Tissue expander (19357) then implant exchange (11970)
Implant-based reconstruction isn’t a single claim; it’s a sequence. 19357 is the first operation, placement of a tissue expander after mastectomy, and it includes the subsequent expansions, the saline fills done over weeks to stretch the skin. 11970 is the second operation, replacing the expander with the permanent implant.
The exchange comes months after the placement, so 11970 is its own date of service — often past 19357’s 90-day global. (Run the surgery date and codes through our global period calculator to see exactly which side of the global any service falls on.) When it does fall inside the global, it carries modifier 58: the planned, staged procedure, paid in full with a new global period, not the reduced modifier-78 payment of an unplanned return to the OR. Miss that, or bill an expansion visit separately when the fills are already bundled into 19357, and the staged claim falls out of alignment. This is implant-based; the autologous free-flap route is different, we cover it in our DIEP flap guide.
What the stages pay, for reference: in 2026 Medicare national terms the expander placement (19357) runs about $1,073 and the exchange (11970) about $517, with the ADM add-on (+15777) around $182 in a facility and revisions like capsulectomy (19371) about $649 or 19380 about $736. These are Medicare national averages; commercial contracts vary, often at a multiple of Medicare, so check your own agreements before you quote a number.
How the ADM technique changes the bill (+15777)
Most implant-based reconstruction uses acellular dermal matrix to support the device, and the matrix carries its own line. The placement is an add-on — +15777, implantation of a biologic implant for soft-tissue reinforcement of the breast — reported with the stage it’s done in, usually the expander placement. And +15777 is the placement only: the matrix product is supplied and billed separately, by the unit, in addition to the code.
That separate product line is where technique changes the money. Anchor the matrix at the inframammary fold as a lower-pole sling and you use one modest piece — a small supply line. Wrap and score the device for total anterior coverage, the prepectoral approach, and you use far more matrix: a large sheet, fenestrated to conform and expand. Total anterior coverage that uses two pieces — a superior anterior sheet plus an inferior sling — can support a second unit of +15777 on commercial payers, though Medicare’s Medically Unlikely Edit caps +15777 at one unit per day. So the operative note has to name the technique and the amount of matrix used, because that supply line, billed in addition to +15777, is where the revenue and the denials live.
Why WHCRA covers the whole reconstruction, not just the first surgery
The coverage backbone here is federal. The Women’s Health and Cancer Rights Act requires plans that cover mastectomy to cover all stages of reconstruction, surgery and reconstruction of the breast on which the mastectomy was performed, plus the procedures needed over time to refine it. Payer policy implements that mandate.
So the energy goes to coding each stage accurately, not to proving necessity. Expander, fills, exchange, and later revisions are each a covered step of one protected benefit. The denial risk isn’t “is this covered,” it’s “did this stage get coded and linked to the mastectomy correctly.” Treat the sequence as one mandated reconstruction billed in parts.
Symmetry surgery and revisions under WHCRA
The part practices most often leave on the table: WHCRA covers surgery on the other, non-cancer breast to produce a symmetrical appearance. A reduction, augmentation, or lift on the contralateral side, done to match the reconstructed breast, is a covered part of the reconstruction, not a cosmetic add-on. WHCRA also covers prostheses and treatment of complications, including lymphedema.
So code the symmetry procedure as the reconstructive step it is, tie it to the mastectomy and the reconstruction, and it holds. Bill it as a standalone cosmetic breast procedure and it denies, even though the law requires its coverage. The link to the qualifying mastectomy is what keeps the contralateral work covered.
Revisions carry their own codes — and their own bundling fight. When a staged reconstruction needs correction, a capsular contracture or a malposition, the work uses codes like 19371 (complete peri-implant capsulectomy) and 19380 (significant revision of the reconstructed breast). WHCRA covers them; treatment of complications is in the mandate. But these sit integral to the primary reconstruction, so NCCI bundles them unless the operative note shows the revision or capsulectomy as distinct, independently necessary work — then they’re separately reportable, generally with modifier 59, or modifier 58 on a planned, staged return. Bill a bundled revision as a separate line without that documentation and the edit denies it; document it as the distinct procedure it was and it holds.
Documenting staged reconstruction for coverage
The staged-reconstruction claim that holds carries the link to the qualifying mastectomy, the stage-appropriate code (19357, then 11970, then revision and symmetry codes), and the laterality. Because WHCRA mandates the benefit and forbids denial based on the time elapsed since the mastectomy, the documentation is about describing each stage precisely, not re-arguing necessity.
Keep the thread visible across dates of service so a stage years later still reads as part of the protected reconstruction. If staged reconstruction claims are denying or getting unbundled, our medical billing operation works the stage coding, the symmetry justification, and the appeals behind them.
Exchanges outside the reconstructive pathway follow different rules — when you can bill insurance for an implant exchange covers that case.
Frequently asked questions
Is tissue expander breast reconstruction covered by insurance?
Yes. The Women’s Health and Cancer Rights Act (WHCRA) requires plans that cover mastectomy to cover all stages of breast reconstruction, including implant-based reconstruction with a tissue expander (CPT 19357) and the exchange to a permanent implant (CPT 11970). Coverage is mandated, so accurate stage coding is the focus.
What CPT codes are used for tissue expander reconstruction?
CPT 19357 reports placement of the tissue expander after mastectomy and includes the subsequent expansions; CPT 11970 reports replacing the expander with a permanent implant. Later refinements, symmetry surgery, and nipple-areola reconstruction (e.g., 19350) carry their own procedure-specific codes.
Is acellular dermal matrix billed separately in implant reconstruction?
Yes. The ADM placement is reported with add-on code +15777, listed in addition to the reconstruction code, and the matrix product is billed separately by the unit on its own HCPCS line. Total anterior coverage uses substantially more matrix than an inframammary-fold sling, and a two-piece total-coverage construct can support a second unit of +15777 on commercial payers, though Medicare’s Medically Unlikely Edit caps +15777 at one unit per day.
Does insurance cover surgery on the other breast after reconstruction?
Yes, under WHCRA. Surgery on the non-cancer breast to produce a symmetrical appearance — a reduction, augmentation, or lift to match the reconstructed breast — is a covered part of the reconstruction when linked to the mastectomy, not a cosmetic procedure. WHCRA also covers prostheses and complications, including lymphedema.
Is there a time limit to get breast reconstruction covered?
No. WHCRA prohibits denying coverage based on the period of time between the mastectomy and the reconstruction request. Reconstruction can be done at the time of mastectomy or years later, and each stage remains a covered part of the protected benefit.
Why was my staged reconstruction claim denied?
Common reasons are billing an expansion visit separately when it’s bundled into 19357, missing or mis-coding the 11970 exchange, coding contralateral symmetry surgery as standalone cosmetic work, or failing to link a later stage back to the qualifying mastectomy.
This article explains how these codes tend to get paid — it is not coding, billing, or legal advice. Some of the codes here are bundled into the main procedure, or fall into grey areas that vary by payer. Before billing anything in a grey area, confirm it with your own coding and compliance team and the current guidance from the American Society of Plastic Surgeons (ASPS), Medicare (CMS), and AMA CPT. When in doubt, don’t bill it.
